Heart rate reduction in coronary artery disease and heart failure

被引:86
作者
Ferrari, Roberto [1 ]
Fox, Kim [2 ,3 ]
机构
[1] Osped Cona, Dept Cardiol, Via Aldo Moro 8, I-44124 Ferrara, Italy
[2] Imperial Coll, Natl Heart & Lung Inst, Sydney St, London SW3 6NP, England
[3] Royal Brompton Hosp, Inst Cardiovasc Med & Sci, Sydney St, London SW3 6NP, England
关键词
CURRENT INHIBITOR IVABRADINE; LEFT-VENTRICULAR FUNCTION; BETA-BLOCKER THERAPY; I-F INHIBITOR; HYPERPOLARIZATION-ACTIVATED CURRENT; SYSTOLIC DYSFUNCTION BEAUTIFUL; LONG-TERM TREATMENT; ATRIAL-FIBRILLATION; MYOCARDIAL-INFARCTION; DOUBLE-BLIND;
D O I
10.1038/nrcardio.2016.84
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated heart rate is known to induce myocardial ischaemia in patients with coronary artery disease (CAD), and heart rate reduction is a recognized strategy to prevent ischaemic episodes. In addition, clinical evidence shows that slowing the heart rate reduces the symptoms of angina by improving microcirculation and coronary flow. Elevated heart rate is an established risk factor for cardiovascular events in patients with CAD and in those with chronic heart failure (HF). Accordingly, reducing heart rate improves prognosis in patients with HF, as demonstrated in SHIFT. By contrast, data from SIGNIFY indicate that heart rate is not a modifiable risk factor in patients with CAD who do not also have HF. Heart rate is also an important determinant of cardiac arrhythmias; low heart rate can be associated with atrial fibrillation, and high heart rate after exercise can be associated with sudden cardiac death. In this Review, we critically assess these clinical findings, and propose hypotheses for the variable effect of heart rate reduction in cardiovascular disease.
引用
收藏
页码:493 / +
页数:9
相关论文
共 112 条
[101]   Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate [J].
Tagliamonte, Ercole ;
Cirillo, Teresa ;
Rigo, Fausto ;
Astarita, Costantino ;
Coppola, Antonino ;
Romano, Carlo ;
Capuano, Nicola .
ADVANCES IN THERAPY, 2015, 32 (08) :757-767
[102]   Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina [J].
Tardif, JC ;
Ford, I ;
Tendera, M ;
Bourassa, MG ;
Fox, K .
EUROPEAN HEART JOURNAL, 2005, 26 (23) :2529-2536
[103]   Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy [J].
Tardif, Jean-Claude ;
O'Meara, Eileen ;
Komajda, Michel ;
Boehm, Michael ;
Borer, Jeffrey S. ;
Ford, Ian ;
Tavazzi, Luigi ;
Swedberg, Karl .
EUROPEAN HEART JOURNAL, 2011, 32 (20) :2507-2515
[104]   Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial [J].
Tardif, Jean-Claude ;
Ponikowski, Piotr ;
Kahan, Thomas .
EUROPEAN HEART JOURNAL, 2009, 30 (05) :540-548
[105]   Quality of Life With Ivabradine in Patients With Angina Pectoris The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy [J].
Tendera, Michal ;
Chassany, Olivier ;
Ferrari, Roberto ;
Ford, Ian ;
Steg, Philippe Gabriel ;
Tardif, Jean-Claude ;
Fox, Kim .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (01) :31-38
[106]   The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers [J].
Thackray, Simon D. R. ;
Ghosh, Justin M. ;
Wright, Graham A. ;
Witte, Klaus K. A. ;
Nikitin, Nikolay P. ;
Kaye, Gerald C. ;
Clark, Andrew L. ;
Tweddel, Ann ;
Cleland, John G. F. .
AMERICAN HEART JOURNAL, 2006, 152 (04) :713.e9-713.e13
[107]   Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status [J].
Vaillant, Fanny ;
Dehina, Leila ;
Dizerens, Nicole ;
Bui-Xuan, Bernard ;
Tabib, Alain ;
Lauzier, Benjamin ;
Chevalier, Philippe ;
Descotes, Jacques ;
Timour, Quadiri .
RESUSCITATION, 2013, 84 (03) :384-390
[108]   Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: Role of myocyte structure and myocardial perfusion [J].
Vaillant, Fanny ;
Dehina, Leila ;
Mazzadi, Alejandro ;
Descotes, Jacques ;
Chevalier, Philippe ;
Tabib, Alain ;
Bui-Xuan, Bernard ;
Riera, Cecile ;
Belhani, Dalila ;
Timour, Quadiri .
RESUSCITATION, 2011, 82 (08) :1092-1099
[109]   The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease, another funny aspect of the funny channel? [J].
van der Hoeven, N. W. ;
van Royen, N. .
HEART, 2014, 100 (02) :98-99
[110]   The discovery of the selective If current inhibitor ivabradine -: A new therapeutic approach to ischemic heart disease [J].
Vilaine, JP .
PHARMACOLOGICAL RESEARCH, 2006, 53 (05) :424-434